CD Skripsi

Pola Penggunaan Obat Antituberkulosis Pada Pasien Tuberkulosis Paru Di Puskesmas Rejosari Kota Pekanbaru Tahun 2022 – 2023

---

Antituberculosis drugs are a combination of antibiotics used to treat tuberculosis, both pulmonary and extrapulmonary tuberculosis. The use of anti-TB drugs must comply with several principles that have been regulated in the National TB Medical Guidelines 2021 by the Indonesian Ministry of Health, including a combination at least 4 types of drugs, the appropriate drug dose, treated for 6 months consisting of initial and continuation phases, also direct observation by the Drug Ingestion Supervisor. The use of anti-TB drugs often causes side effects which is one of the factors why patients are not adhere during treatment. This research is a descriptive study to determine the profile of antituberculosis drug use in pulmonary TB patients at Rejosari primary health center, Pekanbaru city in 2022-2023. This research sample used 106 medical records of pulmonary TB patients who met the criteria. The research results were obtained from 106 samples, the OAT combination for 106 patients (100%) was first line, the drug dose was appropriate for 100 patients (92,5%), the duration of treatment was appropriate for 80 patients (75,5%), the application of PMO was appropriate for 104 patients (98,1%), and anti-TB drug side effects were experienced by 8 patients (7,5%).


Keywords: antituberculosis drugs, pulmonary TB, PMO, side effects of OAT, OAT drug use

---

Ketersediaan

Informasi Detail

Judul Seri

-

No. Panggil

2108110399

Penerbit

Pekanbaru : Universitas Riau FK Pendidikan Dokter., 2024

Deskripsi Fisik

-

Bahasa

Indonesia

ISBN/ISSN

-

Klasifikasi

2108110399

Tipe Isi

-

Tipe Media

-

Tipe Pembawa

-

Edisi

-

Subjek

PENDIDIKAN DOKTER

Info Detail Spesifik

-

Pernyataan Tanggungjawab

Jaka

Versi lain/terkait

Lampiran Berkas

Komentar

---

Anda harus masuk sebelum memberikan komentar